L-base Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

L-base General Information

Description

Developer of an autophagy-targeted drug intended to overcome resistance to existing anticancer drugs. The company intends to develop therapeutic agents that can overcome resistance to targeted anticancer drugs using CAGE-derived peptides, helping patients reduce the possibility of side effects compared to the previous generation of chemotherapy.

Contact Information

Website
www.l-base.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wangshimri-ro 58
  • Seongdong-gu
  • Seoul, 01415
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Wangshimri-ro 58
  • Seongdong-gu
  • Seoul, 01415
  • South Korea
+82

L-base Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

L-base Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 21-May-2024 Completed Pre-Clinical Trials
6. Accelerator/Incubator 08-May-2024 Completed Startup
5. Later Stage VC 01-Jan-2023 Completed Pre-Clinical Trials
4. Later Stage VC (Series B) 01-Jan-2021 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 01-Jun-2018 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Nov-2016 $529K $529K Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view L-base’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

L-base Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an autophagy-targeted drug intended to overcome resistance to existing anticancer drugs. The company intend
Drug Discovery
Seoul, South Korea
3 As of 2024

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

L-base Competitors (1)

One of L-base’s competitors is Deciphera Pharmaceuticals, a Formerly VC-backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Deciphera Pharmaceuticals Formerly VC-backed Waltham, MA
You’re viewing 1 of 1 competitors. Get the full list »

L-base Patents

L-base Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023043271-A1 Method for characterizing responder to cage inhibitor for cancer therapy Inactive 17-Sep-2021
WO-2023043261-A1 Pharmaceutical composition for enhancing anticancer effect of anticancer drug Inactive 17-Sep-2021
US-20250213645-A1 Pharmaceutical composition for modulating immune response Pending 17-Sep-2021
WO-2023043269-A1 Pharmaceutical composition for modulating immune response Inactive 17-Sep-2021
JP-2023522311-A Pharmaceutical composition for cancer prevention or treatment Active 22-Mar-2021 C07K7/06
To view L-base’s complete patent history, request access »

L-base Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

L-base Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Seoul Biohub Accelerator/Incubator
Korea Institute of Startup and Entrepreneurship Development Accelerator/Incubator
Ministry of SMEs and Startups Government
Daewon Pharmaceutical Corporation Minority
Mirakle Lab Accelerator/Incubator Minority
You’re viewing 5 of 11 investors. Get the full list »

L-base FAQs

  • When was L-base founded?

    L-base was founded in 2015.

  • Where is L-base headquartered?

    L-base is headquartered in Seoul, South Korea.

  • What is the size of L-base?

    L-base has 3 total employees.

  • What industry is L-base in?

    L-base’s primary industry is Drug Discovery.

  • Is L-base a private or public company?

    L-base is a Private company.

  • What is L-base’s current revenue?

    The current revenue for L-base is .

  • How much funding has L-base raised over time?

    L-base has raised $10.5M.

  • Who are L-base’s investors?

    Seoul Biohub, Korea Institute of Startup and Entrepreneurship Development, Ministry of SMEs and Startups, Daewon Pharmaceutical, and Mirakle Lab are 5 of 11 investors who have invested in L-base.

  • Who are L-base’s competitors?

    Deciphera Pharmaceuticals is a competitor of L-base.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process